Making science workFind out how

Making science work

Find out how

Development of Oral Liquid Forms  | CN 6751

05.11. - 06.11.2018 | Düsseldorf, Germany

Venue

Holiday Inn Düsseldorf City
Toulouser Allee 5
40211 Düsseldorf
Phone:0049 211 20541 100
Fax:0049 211 20541 899

Workshop programme for download

Description

Oral liquids have been used since decades as preferred dosage forms for children. Since the regulation for pediatric development were set in force by EMA and FDA, age appropriate formulations have received increased relevance. Hence, also oral liquid forms are more frequently developed as pediatric dosage form. The scope of applications will be extended to NCEs, to highly potent drugs, to new fields of indications, and more often to long term treatments.

In addition to the classical field of OTC medications and antibiotics new requirements to oral liquids will play a role. Although solid, single unit dosage forms such as oral disintegrating tablets and dispersible tablets have clear advantages as pediatric formulation in terms of stability, oral liquids as multidose dosage forms provide the clear advantage of flexible dosing, which is particularly important for highly active compounds with narrow therapeutic window.

Target groups

Particularly formulation scientists, who have only limited experiences with liquid dosage forms, or those who strive for gaining a more holistic insight into the development of oral liquid forms should take benefit from this course.

Objective

The seminar should provide an overview of all relevant aspects in the context of developing oral liquid dosage forms, such as oral solution and suspension including also formulations of powder for constitution thereof.

Speaker

Rene Holm

Janssen R&D – a devision of Janssen Pharmaceutica NV, Belgium

Peter Kühl

F. Hoffmann-La Roche AG, Switzerland

Susanne Page

F. Hoffmann-La Roche AG, Switzerland

Registration fee

  Price
Industry 1,490.00 €
Authority / University 745.00 €
Students 178.00 €
All prices free of VAT

Organizer(s)

APV-Office

Dr. Martin Bornhöft
Phone: +49 6131 9769-0
Fax: +49 6131 9769-69
E-mail: apv@apv-mainz.de
www: https://www.apv-mainz.de/